Bohai Pharmaceuticals Group, Inc. Revenue per Employee (BOPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bohai Pharmaceuticals Group, Inc.  (BOPH)
 

Bohai Pharmaceuticals Group's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 7.57% in the first quarter 2015, year on year to cumulative value of $179 million, Bohai Pharmaceuticals Group's revenue per employee grew on a trailing twelve months basis to $ 178,940, this marks a new company high.
Within the Healthcare sector Employees of 76 other companies have achieved higher revenue per employee. While Bohai Pharmaceuticals Group's total ranking has deteriorated compared to the previous quarter from 0 to 1612. Bohai Pharmaceuticals Group has 1,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BOPH Revenue per Employee (Sep 30 2014)
I. Quarter		 (Jun 30 2014)
IV. Quarter		 (Mar 31 2014)
III. Quarter		 (Dec 31 2013)
II. Quarter		 (Sep 30 2013)
I. Quarter
Y / Y Revenue Change 7.57 % 12.47 % 14.19 % -5.52 % 43.96 %
Sales per Employee (TTM) $ 178,940 175,086 170,009 165,074 167,333
BOPH's Total Ranking # 1612 # 0 # 0 # 0 # 0
Seq. Revenue Change 19.52 % 15.31 % 2.71 % -24 % 24.96 %

BOPH Company Profile >> Back to BOPH Efficiency Comparisons >> Compare BOPH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 18
Healthcare Sector # 77
Overall Market # 1612

Revenue per Employee Statistics
High Average Low
$ 178,940 $ 177,013 $ 175,086
(Sep 30 2014)   (June 30. 2014)



Financial Statements
Bohai Pharmaceuticals Group's Revenue MRQ $ 55 Millions Visit BOPH's Income Statement
Bohai Pharmaceuticals Group's Revenues TTM $ 179 Millions Visit BOPH's aggregate revenue growth
What are BOPH's Sales? Visit BOPH's Sales by Segment




Other Ratios
Bohai Pharmaceuticals Group's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BOPH's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BOPH's Competitors
Revenue per Employee for BOPH's Suppliers
Revenue per Employee for BOPH's Customers

You may also want to know
BOPH's Sales Growth Rates BOPH's Pe Price to earnings ratio BOPH's Receivables Turnover Ratio BOPH's Stock Quote
BOPH's Net Income Growth Rates BOPH's Ps Price to Sales ratio BOPH's Sales per Employee BOPH's Asset Turnover Ratio
BOPH's Net Margin BOPH's Pb Price to Book ratio BOPH's Financial Strength Ratios BOPH's Dividend Payout Ratio
Date modified: 2026-08-29T17:35:58+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2014, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2014Number of Employees Sep 30 2014
Harvard Bioscience Inc   313,135.69 $ 106.153  Million 339 
Haemonetics Corporation  309,387.69 $ 935.279  Million 3,023 
Cardiovascular Systems Inc   296,400.00 $ 148.200  Million 500 
Alkermes Plc   295,040.98 $ 604.834  Million 2,050 
Varian Medical Systems Inc   294,040.98 $ 3,049.793  Million 10,372 
Bio rad Laboratories Inc   292,539.60 $ 2,179.420  Million 7,450 
Remedent Inc   290,846.40 $ 2.908  Million 10 
Pacific Health Care Organization Inc  289,425.87 $ 8.972  Million 31 
Psychemedics Corporation  286,405.99 $ 28.927  Million 101 
Tenet Healthcare Corp  283,898.99 $ 28,106.000  Million 99,000 
Myriad Genetics Inc   275,772.59 $ 744.586  Million 2,700 
Phibro Animal Health Corporation  275,295.20 $ 717.144  Million 2,605 
Nrc Health  270,689.08 $ 96.636  Million 357 
Standard Biotools Inc   266,958.87 $ 103.847  Million 389 
Sangamo Therapeutics Inc   266,105.63 $ 37.787  Million 142 
Agilent Technologies inc   265,745.86 $ 4,810.000  Million 18,100 
Stereotaxis Inc   262,017.82 $ 34.324  Million 131 
Regulus Therapeutics Inc   261,882.35 $ 8.904  Million 34 
Cryo cell International Inc   261,284.18 $ 19.858  Million 76 
Davita Inc   259,620.53 $ 20,250.401  Million 78,000 
Masimo Corp  257,859.09 $ 567.290  Million 2,200 
Orthofix Medical Inc   254,130.22 $ 407.879  Million 1,605 
Nuvasive Inc  249,635.33 $ 748.906  Million 3,000 
Waters Corporation  249,483.80 $ 1,970.922  Million 7,900 
Molecular Templates Inc   248,032.26 $ 15.378  Million 62 
Enzo Biochem Inc  240,990.02 $ 96.637  Million 401 
Lifeloc Technologies Inc   235,227.21 $ 8.939  Million 38 
Bard C R Inc  233,647.48 $ 3,247.700  Million 13,900 
Seagen Inc   233,200.83 $ 279.841  Million 1,200 
Xtant Medical Holdings Inc   228,531.01 $ 34.508  Million 151 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.